All In Biotech

Drug Trial Radar · NCT06959082

Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer

A Multi-center, Randomized, Open-label, Parallel-group, Phase 2 Study to Evaluate the Efficacy and Safety of VS-101 in Combination With Chemoradiotherapy (CRT) in Patients With Head and Neck Cancer

Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Jun 11, 2025

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
VSPharmTech Co.,Ltd.Industry
Sponsor type
Industry
First posted
May 6, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This will be a multi-center, randomized, open-label, parallel-group study in adult patients with head and neck cancer.

Conditions

  • Head and Neck Cancer Squamous Cell Carcinoma

Interventions

  • VS-101Drug

    VS-101

  • CisplatinDrug

    Cisplatin

  • RadiationRadiation

    Radiation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective response rate (ORR)Time frame: 6 months and 12 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Yale Cancer Center

    New Haven, Connecticut · Recruiting

  • NYU Langone Health

    Manhattan, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.